XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
  Anorexia Nervosa
  Anxiety
  Bulimia
  CFS
  Child Psychiatry
  Depression
  Forensic Psychiatry
  Learning-Disabilities
  Mood Disorders
   SAD
  Neuropsychiatry
  Peri-Natal Psychiatry
  Personality Disorders
  Psychology
  Psychoses
  Psychotherapy
  Sleep Disorders
  Substance Abuse
  Suicide
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate
Search

Last Updated: Nov 18, 2006 - 1:55:25 PM

SAD Channel
subscribe to SAD newsletter

Latest Research : Psychiatry : Mood Disorders : SAD

   DISCUSS   |   EMAIL   |   PRINT
Light Therapy to treat SAD
Apr 5, 2005 - 5:27:00 PM, Reviewed by: Dr.

"The effect size of the light therapy intervention in our meta-analysis was comparable to what has been described in the clinical literature for conventional medications to treat depression. The findings are as strong or as striking."

 
A study commissioned by the American Psychiatric Association and led by a psychiatrist at the University of North Carolina at Chapel Hill School of Medicine has found that light therapy effectively treats mood disorders, including seasonal affective disorder (SAD) and other depressive disorders.

A report of the study, which appeared April 1 in the American Journal of Psychiatry, also finds that the effects of light therapy, also known as phototherapy, are comparable to those found in many clinical studies of antidepressant drug therapy for these disorders.

The findings were based on a meta-analysis, a systematic statistical review of 20 randomized, controlled studies previously reported in the scientific literature. These represented only 12 percent of 173 published studies that the authors had originally considered for review.

"We found that many reports on the efficacy of light therapy are not based on rigorous study designs. This has fueled the controversy in the field as to whether or not light therapy is effective for SAD or for non-seasonal forms of mood disorders," said lead author Dr. Robert Golden, professor and chairman of psychiatry at UNC and vice dean of the medical school.

"But when you throw out all the studies that are methodologically flawed and then conduct a meta-analysis of those that are well-designed, you find that light therapy is an effective treatment not only for SAD but also for depression."

The use of bright artificial light for people with SAD, a recurring depression that develops in the fall or winter and spontaneously disappears during spring or summer, was first described in the Archives of General Psychiatry in 1984. Since then, the treatment has been tried in clinical and research programs for non-seasonal mood disorders, Alzheimer's disease, jet lag, insomnia, eating disorders and other behavioral problems.

A more recent light therapy approach is "dawn simulation," which attempts to simulate an earlier dawn through exposure to artificial light. This follows the theory that SAD is triggered by the reduced period of bright daylight during winter.

The method attempts to recreate the increased intensity of sunlight that occurs in nature in the summer when the sun rises earlier in the day. "The logic here is that it might put people with seasonal affective disorder into remission," Golden said.

Still, the exact mechanisms by which light therapy works remain unclear, the researchers said.

The studies selected by the authors for inclusion in their meta-analysis were grouped into four categories: bright light for SAD, bright light for non-seasonal depression, dawn simulation for SAD and bright light as an adjunct therapy combined with conventional antidepressants for non-seasonal affective disorder.

These study groups were limited to adults ages 18 to 65 years who met a criterion-based mood disorder diagnosis.

The meta-analysis demonstrated statistically significant treatment effects for SAD, dawn simulation for SAD and bright light treatment of non-seasonal depression, the report said.

"The effect size of the light therapy intervention in our meta-analysis was comparable to what has been described in the clinical literature for conventional medications to treat depression," Golden said. "The findings are as strong or as striking."

More research is needed on the safety of light therapy, particularly among children and the elderly, Golden said. The study did not look at safety or adverse effects, as very few reports contain controlled, or comparison, data on side effects or toxicity, the authors reported.

In addition, they added, the responses of children, adolescents and the elderly to light therapy may differ, compared to non-geriatric adults. For example, at each end of the age spectrum, the requirements for light therapy dosing might differ. Also, children and adolescents may need lower doses than the elderly. "And if eye problems such as cataracts are more prevalent among the elderly, might light therapy aggravate the problem, even slightly?", Golden added.

As to efficacy of light therapy for SAD and other non-seasonal depressive mood disorders, Golden said this study largely answers the question: The treatment is effective.

"The study also points to the importance of conducting systematic literature reviews in areas of controversy using well-defined standards of what constitutes good study design, and to follow this up with meta-analyses so that the data can speak for themselves. "And when you can separate the wheat from the chaff, the findings are much more valid."
 

- April 1 issue of American Journal of Psychiatry
 

www.med.unc.edu

 
Subscribe to SAD Newsletter
E-mail Address:

 

Study co-authors with Golden are Dr. Bradley N. Gaynes, associate professor of psychiatry at UNC; R. David Ekstrom, adjunct assistant professor of psychiatry at UNC; Dr. Robert Hamer, professor of psychiatry at UNC; Dr. Frederick M. Jacobsen, clinical professor of psychiatry at George Washington University; Dr. Trisha Suppes, associate professor and director of the Bipolar Disorder Clinic and Research Program at the University of Texas Southwestern Medical Center; Dr. Katherine L. Wisner, professor of psychiatry at the University of Pittsburgh School of Medicine; and Dr. Charles B. Nemeroff, professor and chairman of psychiatry and behavioral sciences at Emory University.

UNC School of Medicine
By LESLIE H. LANG


Related SAD News
Light Therapy to treat SAD


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us